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Abstract: The objective of this study was to identify urinary metabolite profiles that 
discriminate between high and low intake of dietary protein during a dietary intervention. 
Seventy-seven overweight, non-diabetic subjects followed an 8-week low-calorie diet 
(LCD) and were then randomly assigned to a high (HP) or low (LP) protein diet for   
6 months. Twenty-four hours urine samples were collected at baseline (prior to the 8-week 
LCD) and after dietary intervention; at months 1, 3 and 6, respectively. Metabolite 
profiling was performed by 
1H NMR and chemometrics. Using partial least squares 
regression (PLS), it was possible to develop excellent prediction models for urinary 
nitrogen (root mean square error of cross validation (RMSECV) = 1.63 mmol/L; r = 0.89) 
and urinary creatinine (RMSECV = 0.66 mmol/L; r = 0.98). The obtained high correlations 
firmly establish the validity of the metabolomic approach since urinary nitrogen is a well 
established biomarker for daily protein consumption. The models showed that 
trimethylamine-N-oxide (TMAO) is correlated to urinary nitrogen. Furthermore, urinary 
creatine was found to be increased by the HP diet whereas citric acid was increased by the 
OPEN ACCESSNutrients 2012, 4  113 
 
 
LP diet. Despite large variations in individual dietary intake, differentiated metabolite 
profiles were observed at the dietary group-level.  
Keywords: metabolomics; metabolite profiles; dietary intervention; dietary protein; NMR 
spectroscopy; chemometrics  
 
1. Introduction  
Dietary assessment plays a crucial role in our ability to clarify relationships between dietary 
exposure and disease causation. Therefore, high-quality dietary information is a key issue in 
establishing causality in nutritional studies. The best approach to ascertain valid information of the 
dietary intake is within the context of prospective dietary intervention studies carried out under highly 
controlled conditions. However, well-controlled feeding studies are costly and therefore often contain 
a relatively small number of participants and have short duration. Thus, a considerable proportion of 
our knowledge relating dietary intake to phenotypes and disease risks comes from population studies 
using, for the most part, quantitative food diaries, dietary recalls or food frequency questionnaires. 
Despite being a well accepted methodology, these methods are often inaccurate as they are based on 
self-reported data and can be prone to misreporting because of inadequate recalls [1,2] and especially 
serious underreporting of energy intake has been observed in obese people [3,4]. 
A goal for nutritional metabolomics is to determine a quantitative link between intake of a 
particular nutrient or eating pattern to a particular metabolic profile. The application of metabolomic 
approaches may also help resolving some of the inherent inaccuracy in documenting dietary intake. 
Biomarkers of dietary protein and especially meat and vegetable specific biomarkers are of particular 
importance as a higher meat intake has been associated with several diseases including hypertension, 
type-2 diabetes, cardiovascular disease and cancer [5–7]. In a study by Stella et al. [8] they conducted 
a nuclear magnetic resonance (NMR) metabolomics investigation for the characterization of the 
metabolic effects of vegetarian, low meat, and high meat diets in humans. They found that the high 
meat content diet was associated with elevated urinary levels of creatinine, creatine, carnitine, 
trimethylamine-N-oxide (TMAO), taurine, and 1- and 3-methylhistidine when providing the 3 diets to 
twelve healthy men in a cross-over design. A study by Xu et al. [9] investigated the variability in the 
metabolic urinary profiles from subjects from either lacto-vegetarian or lacto-ovo-vegetarian diets and 
found that plant-based diets were characterized by increased urinary N-acetyl glycosamine (NAG), 
succinate, citrate, phenylalanine, formate and glycine. Nevertheless, it remains unclear how a specific 
dietary composition influences the metabolism and to what extent the turnover of low-molecular-weight 
metabolites are influenced in the long term. A high degree of compliance to the diet is necessary in 
order to obtain valid results, which requires study designs with strict control of the diet, and advanced 
technologies for metabolite analyses. Metabolomic studies on 24 h urine samples in long-term dietary 
intervention trials are still very scarce and much further research is needed. The aim of the present 
study was to identify the metabolites responsible for the discrimination between high vs. low intake of 
dietary protein in the diet after 1, 3 and 6 months, respectively, in a controlled dietary intervention 
when applying a holistic metabolomics approach where no a priori selection of metabolites was made. Nutrients 2012, 4  114 
 
 
2. Experimental Section  
2.1. Study Design 
The present study is an extension of the work that was carried out in the Pan-European DiOGenes 
study. The main aspects of the research conducted in the comprehensive, long-term, randomized, 
controlled dietary intervention study was to address the impact of dietary protein and glycemic index 
(GI) on weight (re)gain in a large number of families in which parents and children suffer from obesity 
or are overweight. A detailed description of the study and further information on the study recruitment, 
exclusion criteria and the investigations carried out at the clinical investigation days have been 
described in two methodological papers [10,11]. The study population in the present study consisted of 
the adult members of the families participating in the intervention study carried out in the Danish 
centre. The study is registered at ClinicalTrials.gov, number NCT00390637. 
2.2. Subjects 
A total of 109 healthy, obese with a body mass index 30.7–37.2 kg/m
2, non-diabetic subjects aged 
37–45 years underwent the clinical investigation day at baseline, which included collection of 24 h 
urine samples. All subjects then underwent an 8-week low-calorie diet treatment before starting the 
dietary interventions. Out of these 101 subjects collected 24 h urine samples after 1 month and   
95 subjects collected 24 h urine samples after 3 months of the dietary intervention period. Finally  
77 (44 women; 33 men) of these subjects also collected 24 h urine samples and underwent the clinical 
investigation day at month 6, at the end of the dietary intervention period. The metabolomic analyses 
in this study included only the 77 subjects who completed the 24 h urine collections at all four time 
points. A schematic presentation of the study design is given in Figure 1. 
Figure 1. Timeline of the part of the DiOGenes study included in the present study and the 
scheduled 24 h urine collections and 3-day weighed food records (WFR). LCD,   
low-calorie diet; HP, high-protein; LP diet, low-protein diet. 
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2.3. Experimental Design 
The current study was designed as a parallel intervention trial with 5 dietary intervention groups 
and the subjects were randomly assigned to a 6-month low-fat (25–30% of energy) diet based on one 
of the following interventions: low protein, low GI (LP/LGI); low protein, high GI (LP/HGI);   
high-protein, low GI (HP/LGI) and high-protein, high GI (HP/HGI) or to a control (CTR) diet 
according to the current Danish official guidelines with an intermediate content of protein. For the 
demographic subject characteristics and the mean dietary macronutrient composition during the   
6-month diet intervention as well as for the analysis aimed at biomarker identification, the two HP 
groups were pooled, as well as the two LP groups in order to average out the variation in carbohydrate 
intake. In this experimental design, 77 subjects were included (42 in the HP and 35 in the LP diet 
group). Furthermore, in these statistical and metabolomics analyses the control group (which included 
a total of 18 subjects) was left out due to the intermediate content of protein but the baseline 
measurements for each group were retained. 
The study subjects were asked to complete a 3-day weighed food record (3d WFR) for three 
consecutive days, including two week days and one weekend day, both at baseline (prior to the 8-week 
LCD), and after randomization to the dietary intervention; at months 1 and 6, respectively.  
The subjects were instructed to weigh all their foods whenever possible and to supply information 
on brand names, cooking and processing. When weighing was not possible (e.g., when dining out) they 
were instructed to record the food in household measures (cups, glasses, tablespoons, etc.). 
To mimic free-living conditions, the 6-month dietary intervention was based on an ad libitum 
design where the families were provided with most food, free of charge, from a trial supermarket at the 
department. The validated supermarket model has been described elsewhere [12]. 
A computer program (DiOGenes, version 1.4; Scientific Nutrition Supervision, Greve, Denmark) 
was constructed for recording of foods (product database) and for the calculation of nutrient composition 
of each shopping session during the 6-month dietary intervention. Local food manufacturers donated 
most products. Additional products were purchased to ensure an appropriate assortment to cover the 
dietary needs and the variability required by all diet groups throughout the 6-month period. The 
products consisted of a broad variety of all kind of foods, and thus the families were exposed to many 
different sources of protein. 
The low protein diets were designed to be low in protein (10–15% of energy), whereas the high 
protein diets prescribed 23–28% of energy from protein. Regarding carbohydrate, the HP diets were 
designed to contain 45–50% of energy from carbohydrates, and the LP diets contained 57–62% of 
energy from carbohydrates. A detailed description of the diets and the dietary strategy is described 
elsewhere [11]. Alcohol consumption was allowed in accordance to the current guidelines issued by 
the Danish National Board of Health, i.e., <14 units/week and <21 units/week (1 unit = 12 g alcohol) 
for women and men, respectively. Subjects were instructed to engage in minimum 30 min/day of 
moderate physical activity to achieve energy balance and weight maintenance, but the actual physical 
activity level was not reported by the subjects. All subjects were allowed a 3-week break from the 
project, during which no recording of the dietary intake was required. The 3-week break was randomly 
distributed throughout the 6 months among the study participants. However, the break was not   Nutrients 2012, 4  116 
 
 
allowed to be less than one week away from the 24 h urine collections and the corresponding 3-day  
dietary records. 
2.4. 24-h Urine Collection and Storage 
Twenty-four hour urine samples were collected both at baseline (prior to the 8-week LCD) and after 
randomization to the dietary intervention; at months 1, 3 and 6, respectively (Figure 1). The subjects 
were each provided with 2 sterile, pre-weighed and airtight 2.5 L polyethylene containers and a sterile 
500 mL container. The subjects were instructed not to collect the first urine-void in the morning on the 
first day, but after this first void, the urine collection started and continued until and including the 
morning urine-void the following day. During the 24 h the subjects were instructed to store the 
containers in the fridge or in another cool place, whenever possible [13]. The subjects were also 
instructed to take a para-aminobenzoic acid (PABA) tablet (240 mg/day) at the morning meal, at lunch 
and at dinner, respectively, as a control of the completeness of urine collection, since PABA is 
absorbed and excreted in the urine within 24 h [14].  
2.5. Urine Sample Handling 
The total volume and density of the collected 24 h urine was determined and two 5 mL aliquots 
from each of the collections were drawn and stored at −80 °C until further preparation and analysis. 
Urinary creatinine concentrations were determined by a colorimetric assay (Ortho-Clinical Diagnostics, 
Johnson & Johnson, Birkeroed, Denmark) for the Vitros 5.1 FS analyzer. Urinary nitrogen was determined 
by Dumas combustion methodology, using a VarioMax CN analyzer (Elemtar, Hanau, Germany), and 
urinary PABA by spectrophotometry (Stasar, Gilford Instruments Laboratories, Oberlin, USA). 
Prior to the NMR analyses of the urine, the samples were thawed at 4 °C, centrifuged at 4 °C at 
1600 rpm for 10 min and then an 340 μL aliquot of the supernatant was added 170 μL of 100 mM 
phosphate buffer (pH 7.4) to reduce the pH range of the samples. Perdeuterated 3-(trimethylsilyl) 
propionate sodium salt (TSP) was added to act as an internal chemical shift reference (δ 1H 0.00),  
10% (v/v) D2O was added to provide a lock signal for the NMR spectrometer and a 0.1% (w/v) NaN3 
was added as a preservative. A Gilson cooling rack kept the samples cooled at 4 °C prior to injection.  
2.6. 
1H NMR Analyses 
1H NMR spectra were acquired on a Bruker DRX 600 MHz spectrometer (Bruker Biospin Gmbh, 
Rheinstetten, Germany) operating at 60,000 MHz for protons (14.09 Tesla) using a broadband inverse 
detection probe head equipped with a 120 μL flow-cell. Data were accumulated at 300 K employing a 
pulse sequence composed by a presaturation of the water resonance during the recycle period followed 
by a composite 90 degree pulse with an acquisition time of 2.73 s, a recycle delay of 2 s, 128 scans and 
a sweep width of 12019.23 Hz, resulting in 64 k complex data points. All samples were individually 
and automatically tuned, matched and shimmed. Prior to Fourier transformation, each free induction 
decay (FID) was zero-filled to 64 k points and apodized by Lorentzian line broadening of 0.30 Hz. The 
resulting spectra were manually phased and automatically baseline corrected using Topspin™ (Bruker 
Biospin) and the ppm scale was referenced towards the TSP peak at 0.00 ppm. Nutrients 2012, 4  117 
 
 
Since the composition and the concentration were very similar for every sample, the receiver gain 
was initially set at a fixed value in order to have a common intensity scale for all the acquired experiments.  
2.7. Pre-Processing of the NMR Spectra 
Before conducting multivariate data analysis (chemometrics) the NMR spectra were cleaned and 
corrected from problems that commonly affect this type of data. First, the NMR regions between  
15.21 and 9.20 ppm, between 6.34 and 4.59 ppm and between 0.62 and −5.61 ppm were removed 
because they included only noise or because the NMR signals of some metabolites (i.e., urea, α and β 
anomeric sugars) were strongly affected by the residual HOD peak. Secondly, the spectra were 
corrected for misalignments in chemical shift primarily due to pH-dependent signals using the   
interval-based icoshift algorithm [15]. No binning was used for the whole chemometric approach, 
therefore full resolution spectra where used avoiding any loss of spectral information. 
In order to find the optimal normalizing method for pre-processing the urine NMR data, two 
different normalization procedures, TSP and volume normalization were tested to find the most 
appropriate PLS model. The PLS calibration models of creatinine are shown in Figure 2.  
Figure 2. Four predicted versus measured plot of creatinine levels. (A) Perdeuterated   
3-(trimethylsilyl) propionate sodium salt (TSP) normalized spectra predicting creatinine 
excretion; (B) TSP normalized spectra predicting creatinine concentration; (C) Volume 
normalized spectra predicting total creatinine excretion; (D) Volume normalized spectra 
predicting total creatinine concentration. The scores have been colored according to 
increasing creatinine concentration; where cyan corresponds to low concentration and 
magenta corresponds to high creatinine concentration.  
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The figure shows four actual versus predicted plots of PLS models predicting creatinine together 
with the model performances (prediction error and correlation coefficient). Figure 2A,B shows the 
result of PLS model of the total excretion of creatinine (mmol/24 h) (A) and the concentration of 
creatinine (mmol/L) (B) respectively, after normalizing the urine spectra according to the area of the 
TSP signals. Furthermore, the actual versus predicted plot of the total excretion of creatinine (Figure 2C) 
and the concentration of creatinine (Figure 2D) are presented after volume normalization. The figure 
clearly demonstrates that TSP area normalization was more suitable when the aim was to   
predict the actual creatinine concentration (correlation coefficient, r = 0.99 and prediction error,   
RMSECV = 0.66 mmol/L). On the other hand the volume normalization was more suitable when the 
aim was to predict its total excretion (mmol/24 h), (correlation coefficient, r = 0.97 and prediction 
error, RMSECV = 1.05 mmol/L). In this study, the primary interest was the concentration of 
metabolites and therefore TSP normalization was chosen for correcting the NMR data.  
Out of 376 spectra, 112 samples were removed from the data set because of either outlying 
behaviour or inadequate PABA recovery. Twenty-two urine samples were considered as outliers due to 
presence of ethanol (1.17 ppm), paracetamol (acetaminophen) (2.18 ppm) and ibuprofen (0.91 ppm), 
which had been consumed by the subjects during the intervention period. Furthermore, the presence of 
acetate (1.91 ppm) indicated bacterial contamination [13]. The resulting 90 samples showed inadequate 
PABA recovery, indicating that the 24-h urine were not complete. 
2.8. Statistics and Multivariate Data Analyses  
Separate mixed linear models were used to assess the time-treatment interaction for the parameters 
BMI, protein, carbohydrate, fat, urinary nitrogen and urinary creatinine. Random effects were included 
to account for heterogeneity between subjects. The analyses were based on the 77 subjects (HP: n = 42 
and LP: n = 35) who completed the 24 h urine collections at baseline, and at months 1, 3 and 6 during 
the dietary intervention period. It was tested whether gender, BMI, PABA, total urine volume, time, 
diet group or dietary components had a significant effect on the total urinary nitrogen or creatinine 
excretion. Where appropriate, variables that significantly affected urinary nitrogen or urinary creatinine 
were used as covariates in the MIXED analyses. Statistical analyses were performed with SAS 
(Statistical Analysis Package version 9.1 for Windows, SAS institute Inc., Cary, NC, USA) and the 
level of significance was P < 0.05.  
Multivariate data analysis in the form of principal component analysis (PCA) and partial least 
squares regression (PLS) was applied to the acquired and preprocessed NMR data to obtain optimal 
quantitative and qualitative information from the measured urine samples. PCA [16] is the fundamental 
approach in exploratory data analysis. With PCA, similarities and differences among samples can be 
highlighted and eventually groups of similarities and the variables (regions in the NMR spectra) 
involved in these differentiations can be inferred. This makes PCA a very useful unsupervised tool for 
a first exploratory approach to unknown data. The complex data matrix in PCA is reduced to few latent 
factors, i.e., principal components (PC’s), sorted by significance (explained variance) which makes it 
easy to distinguish useful information from noise.  
Supervised exploration of dietary parameters was then performed using PLS, which is the primary 
tool for investigating quantitative information from NMR spectra. PLS is a multivariate calibration Nutrients 2012, 4  119 
 
 
method by which two sets of data X (e.g., NMR spectra) and y (e.g., creatine) are related by means of 
regression. In order to group samples e.g., by their dietary intake, PLS discriminant analysis (PLS-DA) 
was chosen as a multivariate data analysis for classification. PLS-DA is a regression model describing 
maximum separation between two pre-defined classes and has been used to predict protein diet   
group [17].  
Assignment of metabolites for an NMR spectrum of a biological sample is a highly complex task as 
resonances from all protons give rise to signals in the NMR spectrum. To investigate the influential 
areas of the spectra, the region selection method: interval PLS (iPLS) [18] proved to be very efficient. 
iPLS is an extension of PLS which develops local PLS models on a number of subintervals of the full 
spectrum region. The main advantage of iPLS is that it provides an overall picture of the relevant 
information in different spectral subdivisions, thereby removing interferences from other regions. iPLS 
reveals areas of the spectra which hold information about the reference data and is thus useful for 
interpretation and assignments. The summarizing iPLS plot shows the most informative region(s) of 
the NMR spectrum which had the lowest prediction error providing a straight comparison with the 
performance of the model obtained using the whole spectra area. Interval based chemometric models 
have previously been shown to be excellent exploratory tools in obtaining knowledge about informative 
regions of the NMR spectrum [13,19,20]. As for any other supervised classification method, careful 
validation is required in order to avoid overfitting the data. For the large data set this was achieved 
using a systematic cross-validation (CV) with five segments, leaving out one segment at a time from 
which the root mean square error of cross-validation (RMSECV) was calculated as a measure of the 
prediction error. However, for the small data sets, due to the low number of samples, full CV was used.  
For the intervals identified as potentially separating diet groups a confirmatory analysis of variance 
(ANOVA) based on the sums of maximum peak intensities was performed to statistically compare diet 
groups. The ANOVAs also included time (1, 3, 6 months) additively to adjust for possible time trends. 
PCA was carried out on the dietary and effect variables at months 1 and 6 of the dietary intervention 
using Latentix 2.0 (www.latentix.com, Latent5, Copenhagen, Denmark). Also the NMR spectra were 
analyzed using the chemometric software LatentiX 2.0 while Matlab
® (2009, The Mathworks Inc., 
Natick, MA, USA) was used for the preprocessing (both normalization and signal alignment) of 
spectral data. The latter was performed using the interval-shifting, icoshift aligning tool [15]. iPLS and 
iPLS-DA were also performed in Matlab using the iToolbox.  
3. Results and Discussion 
3.1. Dietary Intake 
The demographic characteristics of the 77 subjects who completed the study and the mean dietary 
macronutrient composition during the 6 months diet intervention period are presented in Table 1.  Nutrients 2012, 4  120 
 
 
Table 1. Mean dietary macronutrient composition during the 6 months diet intervention 
period (both supermarket data and data provided from the 3-day dietary food diary 
1.  
 
HP diet 
(n = 42) 
LP diet 
(n = 35) 
P 
2 
Main effect  
of time
 
P 
2 
Main effect of 
treatment 
P 
2 
Time × treatment 
interaction 
Men/women  21/21 12/23      
Age (year)  43.9 ± 4.9 
3  42 ± 5.1       
BMI  
Baseline (kg/m
2) 
Month 1 (kg/m
2) 
Month 3 (kg/m
2) 
Month 6 (kg/m
2) 
 
33.9 ± 1.1 
28.0 ± 1.1 
27.9 ± 1.1 
30.6 ± 1.2 
 
34.6 ± 1.2 
28.0 ± 1.3 
29.6 ± 1.3 
30.9 ± 1.3 
<0.0001 
 
NS 
5 NS 
Energy intake  
Baseline (MJ) 
Month 1 (MJ) 
Month 6 (MJ) 
 
10.1 ± 0.5 
6.8 ± 0.5 
5.6 ± 0.5 
 
10.3 ± 0.6 
5.6 ± 0.6 
5.4 ± 0.6 
<0.0001 
 
NS NS 
Protein 
Aim 
Baseline (% E) 
Month 1 (% E) 
Month 6 (% E) 
Supermarket 
Months 0–6 (% E) 
 
23–28 
15.8 ± 0.6 
24.1 ± 0.6 
25.1 ± 0.7 
 
26.6 ± 0.3 
 
10–15 
17.5 ± 0.7 
17.3 ± 0.4 
18.1 ± 0.4 
 
13.9 ± 0.3 
- 
 
 
 
 
 
 
- 
 
 
 
 
 
<0.0001 
<0.0001 
 
 
 
 
 
 
Carbohydrate 
Aim  
Baseline (% E) 
Month 1 (% E) 
Month 6 (% E) 
Supermarket 
Months 0–6 (% E) 
 
45–50 
46.9 ± 1.1 
44.7 ± 1.1 
46.9 ± 1.3 
 
43.6 ± 0.3 
 
57–62 
47.5 ± 1.3 
56.3 ± 1.2 
55.2 ± 1.4 
 
56.2 ± 0.4 
- 
 
- 
 
 
 
 
 
<0.0001 
<0.0001 
 
Fat  
Aim 
Baseline (% E) 
Month 1 (% E) 
Month 6 (% E) 
Supermarket 
Months 0–6 (% E) 
 
25–30 
33.9 ± 1.0 
28.9 ± 1.1 
26.1 ± 1.2 
 
25.8 ± 0.4 
 
25–30 
32.8 ± 1.2 
26.3 ± 1.2 
25.3 ± 1.3 
 
25.3 ± 0.4 
<0.0001 
 
NS 
 
 
 
 
 
NS 
NS 
U-Nitrogen 
4 
Baseline (g/24 h) 
Month 1 (g/24 h) 
Month 3 (g/24 h) 
Month 6 (g/24 h) 
 
14.8 ± 0.6 
15.8 ± 0.6 
17.5 ± 0.6 
16.6 ± 0.6 
 
14.8 ± 0.7 
11.4 ± 0.6 
12.8 ± 0.7 
13.8 ± 0.6 
NS 
 
 
 
 
0.001 NS 
U-Creatinine 
4 
Baseline(mmol/24 h) 
Month 6 (mmol/24 h) 
 
14.8 ± 0.5 
16.1 ± 0.7 
 
14.4 ± 0.6 
13.9 ± 0.6 
NS 
 
 
0.078 
NS 
 
1 HP, high protein; LP, low protein. Supermarket data is based on the sum of energy provided from foods 
collected in the supermarket and from foods acquired from outside the supermarket. 
2 Statistical analyses are 
carried out using PROC MIXED. 
3 x ± SE (all such values). 
4 Adjusted for time, diet group, gender, protein 
intake, BMI, PABA and total urine volume. 
5 NS, non significant. Nutrients 2012, 4  121 
 
 
No differences in baseline data were found and the BMI of the subjects did not differ significantly 
between the two groups (HP and LP). There was a main effect of time indicating that both diet groups 
had a significant weight loss during the 8-week LCD but no significant weight change between groups 
occurred during the 6-month intervention. The actual dietary intake complied with the stipulated diet in 
the two groups, both as reported in the food diary and according to the data obtained from the 
supermarket recordings. Validation of the self-reported dietary intake was performed by assessment of 
the total 24-h urinary excretion of nitrogen and creatinine. The total excretion of nitrogen (at months 1, 
3 and 6, P < 0.0001) and a tendency towards the total excretion of creatinine (month 6, P < 0.078) 
were significantly higher for the HP diets compared to the LP diets.  
In order to provide an overview of the relationship between diet and effect variables at the subject 
level during the 6 months intervention, a PCA model was calculated using the dietary data and the 
corresponding scores and loading plot are shown in Figure 3.  
Figure 3. (A) Principal component analysis (PCA) scores plot for the subjects at month 6 
colored according to diet protein level; (B) Corresponding PCA loading plot of the dietary 
variables (total energy intake (MJ/day), carbohydrate (% of energy), protein (% of energy), 
protein intake (g/day), fat (% of energy), and the effect of variable nitrogen (g/24 h) at 
month 6. ΔBMI is calculated as the BMI change between month 6 and month 1. The 
loading plot illustrates the contribution of each variable to each PC. 
  
The first two principal components (PC’s) describe 56% of the variation. The score plot reveals 
grouping of the subjects according to diet protein group where the subjects following the LP diet are 
located in the negative region of PC1 and the subjects following the HP diet are mainly present in the 
positive region. The subjects on the control diet are situated between the two diet groups as expected. 
Inspecting the first PC using its loading plot it emerges that PC1 describes variation in dietary energy 
with protein intake (total intake (g/day) and % of energy) in the positive direction of PC1 and 
carbohydrate (% of energy) in negative direction and these variables are responsible for the division of 
the diet groups. PC2 is explained by variation in energy intake in the negative direction of PC2 and Nutrients 2012, 4  122 
 
 
protein (% of energy) in the positive direction. Time and fat (% of energy) are correlated but do not 
have a remarkable influence on the model. Total nitrogen excretion (mol/24 h) is closely correlated to 
protein intake (g/day).  
3.2. Validation of NMR Data by Means of Creatinine and Nitrogen Calibration 
In order to investigate and enhance the predictive models of urinary creatinine and nitrogen, iPLS 
models were developed. The iPLS model for prediction of urinary creatinine concentration is shown in 
Figure 4A. The iPLS model was calculated with 54 intervals, each made of 200 variables, and the root 
mean square error of cross validation (RMSECV) of each model is shown for each interval. The iPLS 
plot shows the chemical shift axis in ppm versus RMSECV together with the average spectrum. The 
dotted line represents RMSECV using 4 latent variables (LVs) for the global model identical to the 
model in Figure 4B. The interval containing a large signal at 4.06 ppm has the lowest prediction error 
compared to the global model and the interval with the second lowest RMSECV is the interval 
containing the large singlet at 3.05 ppm. Both these intervals include signals from creatinine. The best 
iPLS model, using 3 LV’s components around 4.06 ppm, is illustrated in Figure 4B, where the 
predicted versus reference values (mmol/L) are plotted. The correlation coefficient of the model was 
high (r = 0.98) and with a low prediction error (RMSECV = 0.69 mmol/L).  
Figure 4. ( A) Interval PLS (iPLS) plot of the prediction of creatinine concentration 
(mmol/L) obtained on 
1H NMR spectra of urine using 54 intervals (200 variables). The 
dotted line shows root mean square error of cross validation (RMSECV) (4 latent variables 
(LV’s)) for global model. The intervals containing signal from creatinine (4.02–4.15;   
2.95–3.05 ppm) show the lowest prediction error; (B) Predicted versus measured plot of PLS 
model calculated on the hatched intervals using 3 LV’s. 
 
Correspondingly an iPLS model on the prediction of urinary nitrogen concentration was calculated, 
and the result is shown in Figure 5A. The model is calculated with 54 intervals of 200 variables each 
and in this case the global model uses 3 LVs as the optimal number of components. The iPLS plot 
reveals that the interval at 3.27 ppm gives the lowest prediction error, which is the interval that 
includes a signal from trimethylamine-N-oxide (TMAO) (hatched interval Figure 5A). The predicted Nutrients 2012, 4  123 
 
 
versus measured plot from this interval is illustrated in Figure 5B. The correlation coefficient of the 
model was high (r = 0.89) and with a low prediction error (RMSECV of 1.63 g/L).  
Figure 5. (A) iPLS plot of the prediction of nitrogen concentration (mmol/L) obtained on 
1H NMR spectra of urine using 54 intervals (200 variables). The dotted line shows 
RMSECV (3 latent variables (LV’s)) for global model. The interval (3.17–3.29 ppm) 
containing signal from trimethylamine-N-oxide (TMAO) shows the lowest prediction 
error; (B) Predicted versus measured plot of PLS model calculated on the hatched intervals 
using 3 LV’s. 
 
One finding of the present study revealed that the TMAO signal in the NMR spectra was highly 
correlated to daily urinary nitrogen excretion. Urinary nitrogen is a well established biomarker of total 
daily protein consumption [14,21,22] and it is thus interesting that urinary TMAO can act as a marker 
associated with the quantity of nitrogen and thereby consumed protein. Recent metabolomic research 
has identified a variety of biomarkers of diets rich in protein and our findings seem to corroborate 
previous studies [8,23–25]. Especially the excretion of TMAO has in several studies shown to be 
elevated after consumption of fish and high-meat diets [8,23,26]. Fish contains high levels of TMAO 
which is naturally synthesized as an antifreeze agent in many types of deep sea fish and thus 
accumulates in the tissues [27]. In a study by Lenz et al. [23] metabolomic urinary profiles collected in 
British and Swedish populations were compared. The urinary profiles were clearly prone to variability 
due to dietary and lifestyle influences. An increased urinary excretion in TMAO was observed in the 
Swedish population as a consequence of a fish-diet, which was not found in the British population. 
Dumas  et al.  [26] conducted a large-scale epidemiological metabolomics study on biochemical 
variability of urinary profiles from populations in Japan, North America, and China. They found that 
high urinary concentrations of TMAO were particularly dominant in the Japanese population, 
consistent with their high dietary intake of fish. However; to our knowledge, the present study is the 
first to highlight the quantitative relationship between reference measurements of creatinine and 
nitrogen and the NMR metabolomic profile. This study showed that TMAO concentration was 
associated with urinary nitrogen excretion and thereby with protein consumed. Since TMAO is present 
in a high concentration in fish and meat it is assumed that this correlation only is valid for animal 
protein sources which may be important in the search for biomarkers of specific protein intake. Nutrients 2012, 4  124 
 
 
3.3. 
1H NMR Spectroscopy of Human Urine 
A 
1H NMR line plot of the complete urine spectra (n = 264) is shown in Figure 6A together with 
assignments of the major metabolites [28–31]. The figure shows the great complexity of 
1H NMR 
spectra of urine as many signals show large variations between the samples. In order to investigate the 
spectra about the diet groups a PCA model of the entire 
1H NMR dataset was calculated and the 
overall variation is illustrated in the score plot shown in Figure 6B.  
Figure 6. (A) 
1H NMR plot of the complete urine spectra (n = 264) from 0.62–9.20 ppm 
including assignments of the most dominant signals; (B) PCA model of 
1H NMR spectra 
showing the overall variation between the samples. The PCA scores are colored according 
to diet group (high protein (HP), low protein (LP) and controls) showing no grouping at 
the individual level according to diet. 
 
The samples in the PCA score plot are colored according to diet group (HP or LP collected at 
months 1, 3 and 6, respectively) and include the baseline samples and control samples. This plot 
reveals large intra- and inter-individual variations and no groupings at the individual level can be 
observed according to diet intervention.  
In order to remove the large inter-individual variation between the samples as shown in Figure 6B, 
the 
1H NMR spectra were pooled to obtain averages of diet groups and remove large unwanted 
variation. The urine spectra were pooled according to the design shown in Figure 7. Only subjects  
(n = 26) from whom samples have been taken at all 4 time points are included in the averaging. Using 
this design the 104 individual spectra were reduced to 12 averaged divided into diet group and gender 
at baseline, months 1 and 6 of the dietary intervention period.  Nutrients 2012, 4  125 
 
 
Figure 7. Averaging design; 104 spectra are reduced to 12 averaged spectra, without 
controls and only including subjects with all four visits and a PABA recovery of min 75%. 
The 12 averaged spectra are divided into diet group (HP or LP) and gender at baseline, 
months 1 and 6. 
 
3.4. Associations Between Dietary Patterns Related to Protein Intake and Human Urinary Metabolites  
To investigate the effect of dietary patterns on the urinary metabolic profiles at group level, an 
iPLS-DA model of 12 averaged spectra from months 1, 3 and 6 was developed. The model was 
calculated on 80 intervals of 135 variables each allowing the use of only 1 LV and yielding   
12 misclassifications for the global model (Figure 8). 
Figure 8 shows two interesting intervals which are able to improve the number of misclassification 
of the global model markedly. These intervals which are colored red (3.86–3.94 + 2.45–2.72 ppm) 
include signals from creatine (3.93 ppm) and the doublets from citric acid (centered at 2.68 and   
2.54 ppm). Inspection of these metabolite signals shows that the discrimination of the HP and LP 
groups is due to the significantly higher creatine intensity of the HP group (P = 0.002) together with a 
significantly lower citric acid content of the urine (P = 0.03) and the reverse behavior was seen for the 
LP group. Furthermore, a tendency towards an increased urinary TMAO with the HP diet was 
observed (figure not shown). The model performance is shown in Figure 8D and reveals an almost 
perfect separation of the two averaged groups. The predicted versus measured plot shows that 
apparently the HP group (actual value = 0) has a higher deviation compared to the LP group (actual 
value = 1) which are predicted more precisely. Nutrients 2012, 4  126 
 
 
Figure 8. (A) iPLS-DA plot of classification of the high protein (HP) and low protein (LP) 
diet from 12 averaged 
1H NMR spectra of urine calculated on 80 intervals (full CV) 
showing the number of misclassification in absolute numbers. The 12 averaged spectra are 
divided into diet group (HP or LP) and gender at months 1, 3 and 6. The red dotted line 
indicates the number of misclassification for the full spectral model together with the 
number of PC. The RMSECV of the global model calculated with 1 LV’s is markedly 
improved by the intervals colored red (3.86–3.94 + 2.45–2.72 ppm). These intervals include 
signals from creatine (3.93 ppm); (B) The RMSECV of the global model calculated with  
1 LV’s is markedly improved by the intervals colored red (3.86–3.94 + 2.45–2.72 ppm). 
These intervals include signals from creatin (3.93 ppm); (C) These intervals include 
doublets from citric acid (centered at 2.86 and 2.54 ppm); (D) The actual versus predicted 
plot shows almost perfect separation of the two diet groups using the selected intervals.  
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In the current study the variability of the metabolic phenotypes of urine samples from subjects of 
both genders following controlled long-term HP or LP diets was investigated. Urinary creatine was 
increased in subjects on HP diets but also a tendency of an increased urinary TMAO was found which 
is in agreement with several other studies investigating biomarkers of HP diets [8,23]. It was suggested 
that the alkali load provided by a high intake of fruit and vegetable increases the intracellular pH, 
meaning that the tubular re-absorption of citric acid decreases and its excretion increases [32].  
3.5. Associations Between Dietary Patterns Related to Protein Intake and Gender-Specific Metabolites  
The 12 averaged spectra from months 1, 3 and 6 were further divided into male and female urine 
spectra and colored according to diet group. The discriminative signals, as observed by visual Nutrients 2012, 4  127 
 
 
inspection, were assigned according to the literature [19,28,31,33,34]. A table of these signals are 
listed in Table 2. The table reveals several complementary metabolites associating with the HP or LP 
diets on the group level. 
Table 2. Identified gender-specific urinary metabolites related to protein intake. 
δ ppm  Female  Male  Chemical assignment 
a 
9.13    HP  Trigonelline (from Caffeine) 
8.84 (triplet)    HP  Trigonelline (from Caffeine) 
8.46   HP  Formate 
4.34  LP    Tartaric acid (grape/wine) 
3.93 HP  HP  Creatine 
3.88 (doublet)  LP    Mannitol 
3.84 (doublet)  LP    Mannitol 
3.75–3.79 LP    Alanine 
3.57 LP    Glycine 
3.43 (triplet)  HP  HP  Taurine 
3.27 HP    TMAO  (trimethylamine-N-oxide) 
3.21   HP  Carnitine 
3.04 HP  HP  Creatine 
2.92 LP    (dimethyl-glycine) 
2.88 HP    TMA  (trimethylamine) 
2.73 LP    DMA  (dimethylamine) 
2.68 (doublet)  LP  LP  Citric acid 
2.54 (doublet)  LP  LP  Citric acid 
2.41   LP  Succinate 
2.32   HP  Taurine 
2.20   HP  Carnitine 
2.27 (triplet)  HP    Taurine 
2.22   LP  Ribose 
2.06 LP    N-acethyl glycosamine (NAG) 
1.48 (doublet)  LP    Alanine 
a Several other NMR signals proved important for gender discrimination but have not been reported because 
not chemically assigned. 
The differentiation between the HP or LP males and HP or LP females revealed alternative 
metabolites describing the difference between protein sources. HP-female urine was characterized by 
TMAO, TMA, and a number of unidentified matabolites, whereas HP-males had a greater urinary 
taurine, carnitine, formate and trigonelline (from caffeine). LP-females had an increased excretion of 
tartaric acid (from grape/wine), mannitol, alanine, glycine and NAG, whereas LP-males had an 
increased excretion of succinate and several unidentified metabolites. Xu et al. found that the most 
influential low molecular weight metabolites characterizing the vegetarians (relative to the omnivorous 
diet group) were increased NAG, succinate, citrate, hippurate and glycine and decreased TMAO, 
taurine, formate, phenylalanine and methylhistidine [9]. Most of these findings except from 
phenylalanine and methylhistidine were confirmed in this study. However, it remains elusive how 
these differences arise from different protein sources consumed in males and females primarily because Nutrients 2012, 4  128 
 
 
of the lack of sufficient robustness of the markers. What is more, the gender distribution showed to be 
rather unbalanced. In the high protein group the gender distribution seemed appropriate, but in the low 
protein group two times more women were found which should be taken into consideration. 
4. Conclusions  
In the present study a holistic metabolomics approach was applied with no a priori selection of 
metabolites. Thereby it was possible to make an explorative investigation of the influence of dietary 
protein exposure on the metabolite profiles at the group level. The study was conducted under highly 
controlled conditions including repeated 24 h urine collections after 1, 3 and 6 months of the dietary 
intervention period and 3-day dietary recordings were collected at the corresponding 3 time-points 
combined with a controlled dietary assessment during the entire 6-month period using the supermarket 
model. The energy intake during the 6 months dietary intervention was ad libitum in order to 
investigate the impact of the diets on weight maintenance after the LCD.  
The study revealed a highly consistent individual correlation between the metabolic profiles and the 
total urinary nitrogen (r = 0.89) and urinary creatinine (r = 0.98). This is considered a major result 
since urinary nitrogen is a well-established biomarker for daily protein consumption and since such a 
high correlation firmly establishes the validity of the exploratory metabolomics approach. Not only can 
the NMR metabolic profiles provide the total nitrogen and the creatinine content, it can also be used 
for validation of and fine tuning of the NMR metabolomics approach and finally give additional and 
simultaneous information about other metabolites and biomarkers that may be relevant for the   
given application.  
The major limitation of the ad libitum free-living 6-month dietary intervention design used in the 
present metabolomics study was the lack of consistency in the diet consumed during the 3-day dietary 
recordings, both within each diet group, within each participant at the 3 different time-points, and 
within the 3 days of dietary recording. As a matter of fact, the 3-day dietary recordings showed a 
decreased energy intake during the intervention most probably caused by energy under-reporting 
which is a common issue in self-reported dietary assessment methods [3,4,35,36] or simply because 
the subjects have been used to the restricted calorie intake during the LCD. As a result of the   
ad libitum intervention design, prediction of protein intake or identification of metabolites relating to 
single individual food items using the data from the 3-day dietary recordings was not successful. 
Nevertheless, differentiated metabolite profiles at the group-level in the HP and LP diet groups was 
observed due to the quantity of protein eaten as a result of the changes induced by long-term exposure. 
Thus, these markers can be interpreted as more general markers, not being confounded by markers 
from single dietary factors. 
Based on the results of the present study, it is recommended that additional validation of the 
potential of TMAO is generated in order to assess its suitability for ranking individuals by their level 
of protein intake. Furthermore, application of complementary analytical techniques with higher 
sensitivity such as LC- or GC-MS will be necessary to identify more detailed metabolite patterns and 
possibly to reach a more individualized level reflecting the dietary patterns imposed here.  Nutrients 2012, 4  129 
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